Form 4: Immunovant's Chief Legal Officer Sells Shares to Cover Tax Obligations

Mark S. Levine, Chief Legal Officer of Immunovant, Inc., sold 4,015 shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.

Summary

• On July 24, 2024, Mark S. Levine, the Chief Legal Officer of Immunovant, Inc., sold 4,015 shares of Immunovant's common stock.
• The shares were sold at a weighted average price of $27.76 per share, with individual transactions ranging from $27.37 to $28.06.
• This sale was to cover tax withholding obligations associated with the vesting of 8,938 restricted stock units (RSUs) on July 19, 2024, which were part of a grant of 143,000 RSUs from January 28, 2022.
• The sale was mandated by Immunovant's policy requiring tax obligations to be funded through a 'sell to cover' transaction, and was not a discretionary transaction by Levine.
• Following the transaction, Levine still beneficially owns 333,394 shares of Immunovant common stock.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (sell to cover taxes) and doesn't provide strong positive or negative signals about the company's prospects.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company executives and employees. This transaction is not necessarily indicative of the executive's sentiment towards the company's future prospects.

Key Dates